Direct comparison of 3 PCR methods in detecting EGFR mutations in patients with advanced non-small-cell lung cancer

Clinical Lung Cancer

Volumn 13, Issue 5, 2012, Pages 369-374

  Ikeda, Takaya ^a   Nakamura, Yoichi ^a   Yamaguchi, Hiroyuki ^a   Tomonaga, Nanae ^a   Doi, Seiji ^b   Nakatomi, Katsumi ^a   Iida, Tetsuya ^a   Motoshima, Kohei ^a   Mizoguchi, Kosuke ^a   Nagayasu, Takeshi ^c   Tsukamoto, Kazuhiro ^c   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sasebo General Hospital   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

EGFR mutations; Mutant enriched PCR; Non Small cell lung cancer; PCR invader; Peptide nucleic acid locked nucleic acid (PNA LNA) PCR clamp

Indexed keywords

CYTOTOXIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB;

ADULT; ADVANCED CANCER; AGED; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; CORNEA ULCER; FALSE NEGATIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; HYPONATREMIA; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATION; NEUTROPENIA; ORAL MUCOSITIS; PARONYCHIA; POLYMERASE CHAIN REACTION; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RASH; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; THROMBOCYTOPENIA;

EID: 84865530167     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.01.008     Document Type: Article

References (30)

1. M. Ono, A. Hirata, T. Kometani Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation Mol Cancer Ther 3 2004 465 472
2. S.W. Han, P.G. Hwang, D.H. Chung Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer Int J Cancer 113 2005 109 115
3. H. Shigematsu, L. Lin, T. Takahashi Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers J Natl Cancer Inst 97 2005 339 346
4. J.G. Paez, P.A. Jnne, J.C. Lee EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
5. T. Mitsudomi, T. Kosaka, H. Endoh Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence J Clin Oncol 23 2005 2513 2520
6. S.W. Han, T.Y. Kim, P.G. Hwang Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib J Clin Oncol 23 2005 2493 2501
7. T. Kosaka, Y. Yatabe, H. Endoh Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications Cancer Res 64 2004 8919 8923
8. M. Tokumo, S. Toyooka, K. Kiura The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers Clin Cancer Res 11 2005 1167 1173
9. T. Mitsudomi, Y. Yatabe Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer Cancer Sci 98 2007 1817 1824
10. T. Mitsudomi, T. Kosaka, Y. Yatabe Biological and clinical implications of EGFR mutations in lung cancer Int J Clin Oncol 11 2006 190 198
11. T. Mitsudomi, S. Morita, Y. Yatabe Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial Lancet Oncol 11 2010 121 128
12. M. Maemondo, A. Inoue, K. Kobayashi Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med 362 2010 2380 2388
13. S.M. Kahn, W. Jiang, T.A. Culbertson Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification Oncogene 6 1991 1079 1083
14. H. Asano, S. Toyooka, M. Tokumo Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay Clin Cancer Res 12 2006 43 48
15. Y. Nagai, H. Miyazawa, Huqun Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp Cancer Res 65 2005 7276 7282
16. V. Lyamichev, A.L. Mast, J.G. Hall Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes Nat Biotechnol 17 1999 292 296
17. K. Tadokoro, M. Kobayashi, T. Yamaguchi Classification of hepatitis B virus genotypes by the PCR-Invader method with genotype-specific probes J Virol Methods 138 2006 30 39
18. H. Kimura, K. Kasahara, M. Kawaishi Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer Clin Cancer Res 12 2006 3915 3921
19. M. Inukai, S. Toyooka, S. Ito Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer Cancer Res 66 2006 7854 7858
20. J. Soh, S. Toyooka, K. Aoe Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer Int J Cancer 119 2006 2353 2358
21. H. Yamaguchi, H. Soda, Y. Nakamura Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer Cancer Chemother Pharmacol 67 2011 331 338
22. T. Tanaka, Y. Nagai, H. Miyazawa Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers Cancer Sci 98 2007 246 252
23. A. Sutani, Y. Nagai, K. Udagawa Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp Br J Cancer 95 2006 1483 1489
24. T.S. Mok, Y.L. Wu, S. Thongprasert Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma N Engl J Med 361 2009 947 957
25. P. Therasse, S.G. Arbuck, E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the united states, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
26. K. Hayakawa, M. Tsuboi Clinical practice guideline for lung cancer [in Japanese] Gan To Kagaku Ryoho 37 2010 609 612
27. R. Maruyama, Y. Nishiwaki, T. Tamura Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer J Clin Oncol 26 2008 4244 4252
28. E.S. Kim, V. Hirsh, T. Mok Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial Lancet 372 2008 1809 1818
29. T. Tanaka, M. Matsuoka, A. Sutani Frequency of and variables associated with the EGFR mutation and its subtypes Int J Cancer 126 2010 651 655
30. K. Naoki, K. Soejima, H. Okamoto The PCR-invader method (structure-specific 5' nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing Int J Clin Oncol 16 2011 335 344